pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 132 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 3
    ficerafusp alfa
    ficerafusp alfa
    Recurrent Head And Neck Squamous Cell Carcinoma$BCAX Bicara Therapeutics Inc.
  • Phase 3
    ficlatuzumab
    ficlatuzumab
    Recurrent Head And Neck Squamous Cell Carcinoma AVEO Pharmaceuticals Inc
  • Phase 3
    furmonertinib mesylate
    furmonertinib mesylate
    Non-Small Cell Lung Cancer$AVBP ArriVent BioPharma, Inc.
← prev
page 3 of 5
next →
131
Pain89
Neurology1
  • Phase 3
    galinpepimut-S
    galinpepimut-S
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)$SLS SELLAS Life Sciences Group, Inc.
  • Phase 3
    glufosfamide
    glufosfamide [INN]
    Metastatic Adenocarcinoma of The Pancreas Eleison Pharmaceuticals Inc
  • Phase 3
    gotistobart
    gotistobart
    Non-Small Cell Lung Cancer OncoC4 Inc
  • Phase 3
    hypericin sodium
    hypericin sodium
    Cutaneous T-Cell Lymphoma$SNGX SOLIGENIX, INC.
  • Phase 3
    ibrilatazar
    ibrilatazar [INN]
    Metastatic Pancreatic Cancer Ability Pharmaceuticals SL
  • Phase 3
    ibudilast
    ibudilast [INN]
    Amyotrophic Lateral Sclerosis$MNOV MEDICINOVA INC
  • Phase 3
    iodine i 131 apamistamab
    Iomab-B (iodine i 131 apamistamab)
    Refractory Acute Myeloid Leukemia$ATNM Actinium Pharmaceuticals, Inc.
  • Phase 3
    ipilimumab + nivolumab
    Opdivo + Yervoy (ipilimumab + nivolumab)
    Gastric Cancer Bristol-Myers Squibb Co
  • Phase 3
    ivospemin hydrochloride
    ivospemin hydrochloride
    Pancreatic Ductal Adenocarcinoma Panbela Therapeutics Inc
  • Phase 3
    izalontamab brengitecan
    izalontamab brengitecan
    Non-Small Cell Lung Cancer Bristol-Myers Squibb Co
  • Phase 3
    lasofoxifene tartrate
    lasofoxifene tartrate
    Human Epidermal Growth Factor Receptor 2 Negative Breast…$LONA LeonaBio, Inc.
  • Phase 3
    lifileucel
    Amtagvi (lifileucel)
    Metastatic Melanoma$IOVA IOVANCE BIOTHERAPEUTICS, INC.
  • Phase 3
    lisaftoclax
    lisaftoclax [INN]
    Myelodysplastic Syndrome (Preleukemia)$AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL
  • Phase 3
    lutadenovec autogene + sapecmeran autogene
    lutadenovec autogene + sapecmeran autogene
    Metastatic Colorectal Cancer Nexoplex Bio LLC
  • Phase 3
    lutetium (177Lu) rosopatamab tetraxetan
    lutetium (177Lu) rosopatamab tetraxetan [INN]
    Metastatic Castration-Resistant Prostate Cancer (mCRPC)$TLX Telix Pharmaceuticals Ltd
  • Phase 3
    lutetium (177Lu) zadavotide guraxetan
    lutetium (177Lu) zadavotide guraxetan
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Curium Midco Sarl
  • Phase 3
    masitinib
    masitinib [INN]
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) AB Science SA
  • Phase 3
    mezigdomide
    mezigdomide
    Refractory Multiple Myeloma Bristol-Myers Squibb Co
  • Phase 3
    mocravimod hydrochloride
    mocravimod hydrochloride
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Priothera Ltd
  • Phase 3
    nadunolimab
    nadunolimab [INN]
    Pancreatic Ductal Adenocarcinoma Cantargia AB
  • Phase 3
    namodenoson
    namodenoson
    Hepatocellular Carcinoma$CANF Can-Fite BioPharma Ltd.
  • Phase 3
    nanvuranlat
    nanvuranlat [INN]
    Metastatic Biliary Tract Cancer J-Pharma Co Ltd
  • Phase 3
    navitoclax dihydrochloride
    navitoclax dihydrochloride
    Myelofibrosis$ABBV AbbVie Inc.
  • Phase 3
    naxtarubicin
    naxtarubicin
    Refractory Acute Myeloid Leukemia$MBRX Moleculin Biotech, Inc.
  • Phase 3
    nibrozetone
    nibrozetone
    Small-Cell Lung Cancer EpicentRx Inc
  • Phase 3
    nivolumab biosimilar
    Bladder Cancer Xbrane Biopharma AB
  • Phase 3
    nofazinlimab
    nofazinlimab [INN]
    Hepatocellular Carcinoma CStone Pharmaceuticals Co Ltd